← All trials
NCT00109382
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2003
- Primary completion
- —
- Completion date
- Feb 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 500
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of CalgaryLead sponsor
- Canadian Institutes of Health Research (CIHR)Collaborator
- Canadian Stroke Consortium (CSC)Collaborator
- University of CalgaryOverall official - principal investigator
- University of OxfordStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.